Listen: Podcast on The Fascinating History of Orphan Drugs

Learn how drugs that no pharmaceutical company wanted to make evolved into extremely lucrative products subsidized by the government.

Congressman Harry Waxman (left), Sharon Dobkin, Abbey Meyers (center), and Adam Seligman (right). / Image: Abbey Meyers
Congressman Harry Waxman (left), Sharon Dobkin, Abbey Meyers (center), and Adam Seligman (right). / Image: Abbey Meyers

A recent episode of the 99% Invisible podcast discussed the fascinating history of orphan drugs. Orphan drugs treat rare diseases that affect so few patients that commercial production doesn’t make financial sense for pharmaceutical companies. However, when a television producer with a rare disease got involved, the issue went viral and lead to reform. The 30-minute podcast is worth the listen, or you can opt for the written article; both are available here.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Sustainable Healthcare Packaging Solutions That Work